The New England journal of medicine, 2023-08, Vol.389 (8), p.687-699
- Grinspoon, Steven K.
- Fitch, Kathleen V.
- Zanni, Markella V.
- Fichtenbaum, Carl J.
- Umbleja, Triin
- Aberg, Judith A.
- Overton, Edgar T.
- Malvestutto, Carlos D.
- Bloomfield, Gerald S.
- Currier, Judith S.
- Martinez, Esteban
- Roa, Jhoanna C.
- Diggs, Marissa R.
- Fulda, Evelynne S.
- Paradis, Kayla
- Wiviott, Stephen D.
- Foldyna, Borek
- Looby, Sara E.
- Desvigne-Nickens, Patrice
- Alston-Smith, Beverly
- Leon-Cruz, Jorge
- McCallum, Sara
- Hoffmann, Udo
- Lu, Michael T.
- Ribaudo, Heather J.
- Douglas, Pamela S.
2023
Details
- Autor(en) / Beteiligte
- Grinspoon, Steven K.
- Fitch, Kathleen V.
- Zanni, Markella V.
- Fichtenbaum, Carl J.
- Umbleja, Triin
- Aberg, Judith A.
- Overton, Edgar T.
- Malvestutto, Carlos D.
- Bloomfield, Gerald S.
- Currier, Judith S.
- Martinez, Esteban
- Roa, Jhoanna C.
- Diggs, Marissa R.
- Fulda, Evelynne S.
- Paradis, Kayla
- Wiviott, Stephen D.
- Foldyna, Borek
- Looby, Sara E.
- Desvigne-Nickens, Patrice
- Alston-Smith, Beverly
- Leon-Cruz, Jorge
- McCallum, Sara
- Hoffmann, Udo
- Lu, Michael T.
- Ribaudo, Heather J.
- Douglas, Pamela S.
- Titel
- Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
- Ist Teil von
- The New England journal of medicine, 2023-08, Vol.389 (8), p.687-699
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2023
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a trial involving participants with HIV infection receiving antiretroviral therapy, the use of pitavastatin resulted in a lower risk of a major adverse cardiac event than placebo at a median of 5.1 years.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2304146Titel-ID: cdi_proquest_miscellaneous_2841879388
- Format
- –
- Schlagworte
- AIDS, Angina, Antiretroviral therapy, Atherosclerosis, Cardiology, Cardiology General, Cardiovascular disease, Cardiovascular diseases, Cardiovascular Diseases - epidemiology, Cardiovascular Diseases - prevention & control, CD4 antigen, Cerebral infarction, Cholesterol, Coronary Disease, Coronaviruses, COVID-19, Design, Diabetes mellitus, Double-Blind Method, Drug therapy, Heart attacks, HIV, HIV Infections - complications, HIV Infections - drug therapy, Human immunodeficiency virus, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Infections, Infectious Disease, Ischemia, Lipids, Low density lipoprotein, Middle Aged, Myocardial Infarction, Myocardial Infarction - epidemiology, Myocardial Infarction - prevention & control, Placebos, Prevention, Quinolines - adverse effects, Statins, Statistical analysis, Transient ischemic attack